Tony Wang
1 followers · 680 views
on the atlas · 11
- 【護理 ‧ 和你一樣】 2023成大醫院護師節微電影 - YouTube1 savers
- Calcinosis cutis: Etiology and patient evaluation - UpToDate1 savers
- Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody - PubMed1 savers
- eHåndbok - NBMDR - Guidelines for Subsequent Donations1 savers
- C. Franco-Paredes - Cutaneous Mycobacterial Infections1 savers
- 005557 - NOD.Cg-Prkdc<scid> Il2rg<tm1Wjl>/SzJ1 savers
- The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: Etiology and clinical work-up - PubMed1 savers
- The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan - PubMed1 savers
- Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review | Dermatology | JAMA | JAMA Network1 savers
- Pustular Psoriasis: The Dawn of a New Era | Abstract | Acta Dermato-Venereologica1 savers
- Pharmacological Management of Pediatric Pustular Psoriasis - PubMed1 savers
highlights · 14
Idiopathic calcinosis cutis
Calcinosis cutis: Etiology and patient evaluation - UpToDateAlthough these patients had a relatively low mortality rate, they were prone to recurrence, and treatment was challenging.
Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody - PubMedextremely immunodeficient.
005557 - NOD.Cg-Prkdc<scid> Il2rg<tm1Wjl>/SzJexcess sweating creates significant emotional, physical, or social discomfort,
The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: Etiology and clinical work-up - PubMedexcess sweating creates significant emotional, physical, or social discomfort
The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: Etiology and clinical work-up - PubMeddaily glucocorticoid use ≥5mg
The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan - PubMedelderly patient >65 year-old
The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan - PubMedThere was no significant difference in TB risk between adalimumab and etanercept users with an incidence rate ratio of 1.27
The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan - PubMedAn example of targeted phototherapy is excimer light therapy, which emits high-intensity UV-B (308 nm)
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review | Dermatology | JAMA | JAMA Networkpsoriasis is approximately 40% if both parents are affected, 14% if one parent is affected, and 6% if a sibling is affected
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review | Dermatology | JAMA | JAMA NetworkHLA-Cw6, HLADQ* 02:01, CCHCR1, and CYP1A1
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review | Dermatology | JAMA | JAMA NetworkRisk factors for the development of psoriasis include genetic, environmental, and behavioral factors, with genetic factors being the largest contributor
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review | Dermatology | JAMA | JAMA NetworkIL36RN, CARD14 and AP1S3
Pustular Psoriasis: The Dawn of a New Era | Abstract | Acta Dermato-VenereologicaEtanercept is the first biological agent approved for juvenile plaque psoriasis, followed by adalimumab
Pharmacological Management of Pediatric Pustular Psoriasis - PubMed